Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference44 articles.
1. Lee JH, Sung T-E, Kim E, Shin K. Evaluating determinant priority of license fee in biotech industry. J Open Innov: Technol, Mark Complex. 2018;4(3):30.
2. DiMasi J, Hermann J, Twyman K, Kondru R, Stergiopoulos S, Getz K, et al. A tool for predicting regulatory approval after phase II testing of new oncology compounds. Clin Pharmacol Ther. 2015;98(5):506–13.
3. Kim J. Development duration analysis on the new molecular entity pipelines of pharmaceutical firms in Korea. Seoul: Sungkyunkwan University; 2018.
4. Thomas D, Micklus A, LaFever S. Clinical development success rates and contributing factors 2011–2020. 2021.
5. Moon H. Basic analysis of the pharmaceutical industry. 2011.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献